Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 10:20 PM
Ignite Modification Date:
2025-12-26 @ 10:20 PM
NCT ID:
NCT02168712
Eligibility Criteria:
Inclusion Criteria:
* Coronary heart Disease, with functional class II-III according to New York Heart Association classification system.
* At least 4 weeks from acute cardiac event, percutaneous or surgery revascularization.
* Optimized medical treatment in adequate doses ( betablockers, ACE inhibitors, ARA II, statins and antiplatelet drugs)
* Age \> 18 years old.
* Willing to participate and sign an informed consent form
Exclusion Criteria:
* Residual ischemia waiting for revascularization.
* Any cardiac event for the last 4 weeks
* Abnormal Ergometry with hemodynamic or clinically significant arrhythmias during the procedure.
* History of severe ventricular arrhythmia
* Uncontrolled glycaemia or blood pressure
* Moderate to severe Chronic Pulmonary Obstructive Disease
* Osteomuscular and/or mental disorder that hampers an adequate adherence to the intervention program
* Other vascular diseases: rheumatologic/ autoimmune disorders, thrombopathies, hemophilia.
* Active oncologic disease.
* Treatment with corticosteroids.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02168712
Study Brief:
Protocol Section:
NCT02168712